INTEGRATED BIOPHARMA INC (INBP) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $54.35M | +8.0% |
| 2024 | $50.32M | -0.7% |
| 2023 | $50.67M | -9.9% |
| 2022 | $56.25M | -11.5% |
| 2021 | $63.56M | +20.4% |
| 2020 | $52.77M | +5.6% |
| 2019 | $49.98M | +14.3% |
| 2018 | $43.71M | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $54.35M | +8.0% |
| 2024 | $50.32M | -0.7% |
| 2023 | $50.67M | -9.9% |
| 2022 | $56.25M | -11.5% |
| 2021 | $63.56M | +20.4% |
| 2020 | $52.77M | +5.6% |
| 2019 | $49.98M | +14.3% |
| 2018 | $43.71M | — |